JillPCrandallMD

Diabetes, Obesity

Professor, Medicine, Endocrinology, Albert Einstein College of Medicine Chief, Division of Endocrinology

Dr. Crandall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Jill Crandall is an endocrinologist in Bronx, NY and is chief of the Division of Endocrinology at Montefiore Medical Center / Albert Einstein College of Medicine. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 29 years. She specializes in diabetes and obesity and is an experienced clinical investigator. She has more than 100 publications and over 500 citings.

New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1991 - 1994
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1988 - 1991
State University of New York Downstate Medical Center College of MedicineClass of 1988

PubMed

Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus.
Youngshin Keum, Maria Luiza Caramori, David Z Cherney, Jill P Crandall, Ian H de Boer
Clinical Journal of the American Society of Nephrology. 2024-10-18
2 citations
Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes.
Claire J Hoogendoorn, Raymond Hernandez, Stefan Schneider, Mark Harmel, Loree T Pham
Journal of Diabetes Science and Technology. 2024-09-01
Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure.
Christine G Lee, Adam Ciarleglio, Sharon L Edelstein, Jill P Crandall, Dana Dabelea
Diabetes Care. 2024-05-01

Lectures

Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight Humans
Bronx, NY - 6/15/2014

People Are Taking a Diabetes Drug for Weight Loss—No, It's Not OzempicDecember 16th, 2024
Continuous Glucose Monitors for All? Opinions Remain MixedNovember 12th, 2024
Low-Carb Diet May Enable Type 2 Diabetics to Reduce MedicationOctober 22nd, 2024
Join now to see all

Diabetes Prevention Program Long-Term Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
Humanin And Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
Clinical CoreNational Institute On Aging2007–2011
Post-Dpp Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
DpposNational Center For Research Resources2004–2008
CvriskNational Center For Research Resources2004–2008
Post-Dpp Follow-Up StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2003
Thrombogenicity In Diabetes MellitusNational Center For Research Resources1999–2002